Yelin Lapidot Holdings Management Ltd. Buys 89,122 Shares of InMode Ltd. $INMD

Yelin Lapidot Holdings Management Ltd. raised its stake in shares of InMode Ltd. (NASDAQ:INMD) by 29.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 387,005 shares of the healthcare company’s stock after acquiring an additional 89,122 shares during the quarter. InMode makes up 1.1% of Yelin Lapidot Holdings Management Ltd.’s portfolio, making the stock its 24th largest holding. Yelin Lapidot Holdings Management Ltd. owned about 0.61% of InMode worth $5,294,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Blue Trust Inc. boosted its stake in shares of InMode by 69.4% in the 1st quarter. Blue Trust Inc. now owns 5,567 shares of the healthcare company’s stock valued at $76,000 after purchasing an additional 2,281 shares in the last quarter. Baron Wealth Management LLC acquired a new stake in shares of InMode during the 1st quarter worth about $262,000. Westmount Partners LLC bought a new position in InMode during the 1st quarter valued at about $267,000. DGS Capital Management LLC lifted its holdings in InMode by 127.7% during the 4th quarter. DGS Capital Management LLC now owns 79,613 shares of the healthcare company’s stock valued at $1,170,000 after purchasing an additional 44,654 shares during the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in InMode in the fourth quarter valued at about $1,045,000. 68.04% of the stock is owned by institutional investors.

InMode Stock Performance

Shares of NASDAQ:INMD opened at $14.63 on Monday. The business has a fifty day moving average of $13.92 and a 200-day moving average of $14.13. InMode Ltd. has a twelve month low of $12.72 and a twelve month high of $16.74. The firm has a market cap of $840.70 million, a PE ratio of 10.75 and a beta of 1.94.

InMode (NASDAQ:INMD) last issued its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.25 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). The company had revenue of $82.02 million for the quarter, compared to the consensus estimate of $79.84 million. InMode had a return on equity of 13.47% and a net margin of 23.27%.The firm’s revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.31 EPS.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on INMD shares. Barclays set a $19.00 price objective on shares of InMode and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Robert W. Baird cut their target price on shares of InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, InMode has a consensus rating of “Hold” and a consensus target price of $16.00.

InMode Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.